1[1]Screation GR. Bemv, Juchson DG. et al. Genomic structure of DNA encoding the lyphocyte noming receptor CD44 reveals at least 12 alter nativelysploced exons [J]. Proc Natl Acad Sci USA, 1992,89:12160
2[2]Yohko V Katagiri,Jonathan Sleeman, et al.CD44 vaniants but not CD44S cooperate with βcontaining integrins to permit cells to bind to osteopontin independently of Arging - gylcine - aspartic Acod, there by stimulating cell motility and is chemotaxis [ J]. Cancer Res, 1999,59:219 - 226.
3[3]Ursula Gunthert, Martin Hofmann, Wolfgang Rudy, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells [J].Cell, 1991,65:13 - 24.
4[4]Saito H,Tsujitanis,Katanok,et al. Serum concentration of CD44 variant 6and is relation to prognosis in patients with gastric carcinoma [ J ].Cancer, 1998,15:1094.
5[5]Yamamichi K, Vehara Y, kitanura N, et al. Increased expression of CD44v6 mRNA Significantly correlates with distant metastasis and poor prognosis in gastric cancer [ J ]. Int J Cancer, 1998,19: 256.
6[6]Stephan Martin, Frank Jansen, Johannes Bolelmann, et al. Soluble CD44splice variants in metastasing human breast cancer[J]. Int J Cancer,1997,74:443 - 445.
7[7]Fichtner, A, Dehmel, H. Naundorf, et al. Expression of CD44 standard and is oforms in human breast cancer xenografts and shedding of soluble foms into serum of nude mice[ J]. Anticancer Res, 1997,17: 3633 - 3646.
8[8]Peter Dall, Kant - Heinz, Heide, Hans - peter Sinn, et al. comparison of immunohistochemistry and Rt - PCR for detection of CD44 - expression,A new prognostic factor in human breast cancer[J]. Int J Cancer, 1995,60:471 - 477.
9[9]Lukas Hefler, Clemens Tempfer, Gwenther Haeusler, et al. Cytosob concentration of CD44 isoforms in breast cancer tissue [J]. Int J Cancer,1998,79: 541 - 545.
10[10]Manfred kanfmann, Kar - Heiz. Heider, Hans - peter Sinn, et al. CD44vaniant exon epitopes in primary breast cancer and lenght of survival [J].The Lancet, 1995,345:615 - 619.
